Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2154609 | 0.93 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL816707 | 0.90 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL14156178 | 0.86 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL14156046 | 0.82 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL1312119 | 0.80 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL5037304 | 0.80 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL13698384 | 0.78 | CYP1A2 (0.33) | ALDH1A1 | |
| SCHEMBL8913308 | 0.76 | ALDH1A1 (0.47) | ALDH1A1TSHR | |
| SCHEMBL18774737 | 0.76 | TAS1R3 (0.33) | ALDH1A1 | |
| SCHEMBL22661237 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| WO-2007064227-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | MAG, MSR1, FABP7 | ALDH1A1 2448/4885TSHR 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.